Skip to content
Log in

Author

Chenggong Fu

View on Semantic Scholar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Discovery of novel RIPK3 inhibitors by virtual screening and bioactivity evaluation.

An integrated virtual screening strategy based on molecular fingerprint similarity, pharmacophore models, molecular docking, and molecular dynamics simulation is proposed and three promising lead compounds targeting RIPK3 for AD treatment are offered.

Chenggong Fu, Qin Li, Yuwei Yang et al. · 0 citations